Experienced in Stroke

Dr. Kore Liow

Neurology
Hawaii Center For Reproductive Medicine And Surgery
642 Ulukahiki St Ste 300, 
Kailua, HI 
Offers Telehealth

Experienced in Stroke
Hawaii Center For Reproductive Medicine And Surgery
642 Ulukahiki St Ste 300, 
Kailua, HI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kore Liow is a Neurologist in Kailua, Hawaii. Dr. Liow is rated as an Experienced provider by MediFind in the treatment of Stroke. His top areas of expertise are Seizures, Epilepsy, Memory Loss, and Generalized Tonic-Clonic Seizure.

His clinical research consists of co-authoring 51 peer reviewed articles and participating in 14 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Stroke.

Specialties
Neurology
Licenses
Psychiatry & Neurology in KS
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
AlohaCare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Hawaii Medical Assurance Association
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Hawaii Center for Reproductive Medicine and Surgery
642 Ulukahiki St Ste 300, Kailua, HI 96734
Call: 808-261-4476
Other Locations
Hawaii Medical Center East
2230 Liliha St, Honolulu,, HI 96817
Call: 808-261-4476

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


14 Clinical Trials

A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants With Parkinson's Disease
A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants With Parkinson's Disease
Enrollment Status: Active_not_recruiting
Publish Date: October 23, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Active-controlled, Double-blind, Double-dummy, Parallel-group Clinical Trial, Investigating the Efficacy, Safety, and Tolerability of Continuous Subcutaneous ND0612 Infusion in Comparison to Oral IR-LD/CD in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (BouNDless)
A Multicenter, Randomized, Active-controlled, Double-blind, Double-dummy, Parallel-group Clinical Trial, Investigating the Efficacy, Safety, and Tolerability of Continuous Subcutaneous ND0612 Infusion in Comparison to Oral IR-LD/CD in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (BouNDless)
Enrollment Status: Active_not_recruiting
Publish Date: May 21, 2025
Intervention Type: Drug, Combination product
Study Drugs: ND0612 Solution, Carbidopa, Levodopa
Study Phase: Phase 3
A Randomized, Placebo-Controlled, Double-Blind Study of ATH-1017 Treatment in Subjects With Mild to Moderate Alzheimer's Disease
A Randomized, Placebo-Controlled, Double-Blind Study of ATH-1017 Treatment in Subjects With Mild to Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: April 04, 2025
Intervention Type: Drug
Study Drug: ATH-1017
Study Phase: Phase 2/Phase 3
CORE-VNS: Comprehensive Outcomes Registry in Subjects With Epilepsy Treated With Vagus Nerve Stimulation Therapy
CORE-VNS: Comprehensive Outcomes Registry in Subjects With Epilepsy Treated With Vagus Nerve Stimulation Therapy
Enrollment Status: Completed
Publish Date: November 22, 2024
Intervention Type: Device
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)
Enrollment Status: Terminated
Publish Date: October 29, 2024
Intervention Type: Drug
Study Drug: TAK-994
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of Three Dose Strengths of T3D-959 in Subjects With Mild-to-Moderate Alzheimer's Disease
A Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Evaluate the Safety and Efficacy of Three Dose Strengths of T3D-959 in Subjects With Mild-to-Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: July 19, 2024
Intervention Type: Drug
Study Drug: T3D-959
Study Phase: Phase 2
An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
Enrollment Status: Completed
Publish Date: May 14, 2024
Intervention Type: Drug
Study Drug: YKP3089
Study Phase: Phase 3
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)
Enrollment Status: Terminated
Publish Date: December 26, 2023
Intervention Type: Drug
Study Phase: Phase 2
A 6-Month Multicenter, Open-Labelled Extension of the Clinical Trial NLS-1021 in Narcoleptic Patients With and Without Cataplexy
A 6-Month Multicenter, Open-Labelled Extension of the Clinical Trial NLS-1021 in Narcoleptic Patients With and Without Cataplexy
Enrollment Status: Completed
Publish Date: March 13, 2023
Intervention Type: Drug
Study Drug: Mazindol
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of Posiphen® in Subjects With Early Alzheimer's Disease (AD) or Early Parkinson's Disease (PD)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of Posiphen® in Subjects With Early Alzheimer's Disease (AD) or Early Parkinson's Disease (PD)
Enrollment Status: Completed
Publish Date: February 28, 2023
Intervention Type: Drug
Study Drug: Posiphen
Study Phase: Phase 1/Phase 2
A Four-week, Double-blind, Placebo-controlled, Randomized, Multicenter, Parallel-group Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in Adults for the Treatment of Narcolepsy
A Four-week, Double-blind, Placebo-controlled, Randomized, Multicenter, Parallel-group Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in Adults for the Treatment of Narcolepsy
Enrollment Status: Completed
Publish Date: August 12, 2022
Intervention Type: Drug
Study Drug: Mazindol
Study Phase: Phase 2
An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Buccal Film (DBF) in Pediatric, Adolescent and Adult Subjects With Epilepsy
An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Buccal Film (DBF) in Pediatric, Adolescent and Adult Subjects With Epilepsy
Enrollment Status: Completed
Publish Date: August 05, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Double-Blind, Placebo-Controlled, Inpatient, Dose-Ranging Efficacy Study of Staccato Alprazolam (STAP-001) in Subjects With Epilepsy With a Predictable Seizure Pattern
A Double-Blind, Placebo-Controlled, Inpatient, Dose-Ranging Efficacy Study of Staccato Alprazolam (STAP-001) in Subjects With Epilepsy With a Predictable Seizure Pattern
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia
A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia
Enrollment Status: Terminated
Publish Date: December 03, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 13 Less Clinical Trials

51 Total Publications

Analysis of the National Institutes of Health COVID-19 Neuro Databank by geographic region and income status.
Analysis of the National Institutes of Health COVID-19 Neuro Databank by geographic region and income status.
Journal: Research square
Published: November 24, 2025
View All 51 Publications
Similar Doctors
Distinguished in Stroke
Dr. Kazuma Nakagawa
Neurology
Distinguished in Stroke
Dr. Kazuma Nakagawa
Neurology

Queens University Medical Group

1301 Punchbowl St, 
Honolulu, HI 
 (1.5 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kazuma Nakagawa is a Neurologist in Honolulu, Hawaii. Dr. Nakagawa is rated as a Distinguished provider by MediFind in the treatment of Stroke. His top areas of expertise are Stroke, Subarachnoid Hemorrhage, Cerebral Arteriovenous Malformation, Stent Placement, and Transmyocardial Revascularization.

Distinguished in Stroke
Dr. Melvin C. Wong
Neurology
Distinguished in Stroke
Dr. Melvin C. Wong
Neurology
98 -1247 Kaahumanu St, Suite 318, 
Aiea, HI 
 (7.7 miles away)
808-487-7960
Languages Spoken:
English, Japanese, Mandarin, Swedish
See accepted insurances
Accepting New Patients
Offers Telehealth

Melvin Wong is a Neurologist in Aiea, Hawaii. Dr. Wong is rated as an Advanced provider by MediFind in the treatment of Stroke. His top areas of expertise are Stroke, Transient Ischemic Attack (TIA), Transient Global Amnesia, and Methylmalonic Acidemia with Homocystinuria. Dr. Wong is currently accepting new patients.

Distinguished in Stroke
Dr. Matthew A. Koenig
Neurology
Distinguished in Stroke
Dr. Matthew A. Koenig
Neurology

Queens University Medical Group

1301 Punchbowl St, 
Honolulu, HI 
 (1.5 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Matthew Koenig is a Neurologist in Honolulu, Hawaii. Dr. Koenig is rated as an Advanced provider by MediFind in the treatment of Stroke. His top areas of expertise are Stroke, Subarachnoid Hemorrhage, Apoplexy, Endovascular Embolization, and Transmyocardial Revascularization.

VIEW MORE STROKE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Liow's expertise for a condition
ConditionClose
    • Distinguished
    • Epilepsy
      Dr. Liow is
      Distinguished
      . Learn about Epilepsy.
      See more Epilepsy experts
    • Seizures
      Dr. Liow is
      Distinguished
      . Learn about Seizures.
      See more Seizures experts
    • Advanced
    • Absence Seizure
      Dr. Liow is
      Advanced
      . Learn about Absence Seizure.
      See more Absence Seizure experts
    • Alzheimer's Disease
      Dr. Liow is
      Advanced
      . Learn about Alzheimer's Disease.
      See more Alzheimer's Disease experts
    • Autosomal Dominant Partial Epilepsy with Auditory Features
      Dr. Liow is
      Advanced
      . Learn about Autosomal Dominant Partial Epilepsy with Auditory Features.
      See more Autosomal Dominant Partial Epilepsy with Auditory Features experts
    • Benign Rolandic Epilepsy
      Dr. Liow is
      Advanced
      . Learn about Benign Rolandic Epilepsy.
      See more Benign Rolandic Epilepsy experts
    • Cerebellar Degeneration
      Dr. Liow is
      Advanced
      . Learn about Cerebellar Degeneration.
      See more Cerebellar Degeneration experts
    • Dementia
      Dr. Liow is
      Advanced
      . Learn about Dementia.
      See more Dementia experts
    View All 11 Advanced Conditions
    • Experienced
    • Anosmia
      Dr. Liow is
      Experienced
      . Learn about Anosmia.
      See more Anosmia experts
    • Aplasia Cutis Congenita
      Dr. Liow is
      Experienced
      . Learn about Aplasia Cutis Congenita.
      See more Aplasia Cutis Congenita experts
    • Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
      Dr. Liow is
      Experienced
      . Learn about Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy.
      See more Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy experts
    • Clouston Syndrome
      Dr. Liow is
      Experienced
      . Learn about Clouston Syndrome.
      See more Clouston Syndrome experts
    • Congenital Cardiovascular Shunt
      Dr. Liow is
      Experienced
      . Learn about Congenital Cardiovascular Shunt.
      See more Congenital Cardiovascular Shunt experts
    • Conversion Disorder
      Dr. Liow is
      Experienced
      . Learn about Conversion Disorder.
      See more Conversion Disorder experts
    View All 33 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Close
        0 / 1000

        Please provide us with the below insurance information:

                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.